Although the percentage of CD45+ immune cells varied noticeably in individual tumours, CD14+ monocyte cells were the most dominant population within all tumours, representing over 90% of the CD45-positive immune infiltrate in samples tested (Supplementary Table S2). The gene discussed is PTPRC; the disease is neoplasm.